ClinicalTrials.govpublic full text
Multimetabolic 18F-Fluorodeoxyglucose (FDG) and 18F-Fluorocholine (FCH) Positron Emission Tomography (PET) as an Early Predictive Factor of Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib
carcinoma, hepatocellular, fdg pet, fch pet, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 867757
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.